I really do think that it’s a good thing. I mean, you need to be able to understand what the construction going on is." ...

It received a tentative approval from the USFDA for a New Drug Application (NDA) for Sitagliptin base tablets. During the year, 2022 Sentynl entered into an asset purchase agreement with BridgeBio ...